Puma Biotechnology Statistics
Total Valuation
PBYI has a market cap or net worth of $412.79 million. The enterprise value is $327.20 million.
Important Dates
The next estimated earnings date is Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PBYI has 50.90 million shares outstanding. The number of shares has increased by 2.74% in one year.
| Current Share Class | 50.90M |
| Shares Outstanding | 50.90M |
| Shares Change (YoY) | +2.74% |
| Shares Change (QoQ) | -1.31% |
| Owned by Insiders (%) | 15.27% |
| Owned by Institutions (%) | 66.92% |
| Float | 38.98M |
Valuation Ratios
The trailing PE ratio is 16.95 and the forward PE ratio is 30.32.
| PE Ratio | 16.95 |
| Forward PE | 30.32 |
| PS Ratio | 1.82 |
| Forward PS | 2.33 |
| PB Ratio | 3.21 |
| P/TBV Ratio | 4.61 |
| P/FCF Ratio | 7.70 |
| P/OCF Ratio | 7.70 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 8.30, with an EV/FCF ratio of 6.11.
| EV / Earnings | 13.42 |
| EV / Sales | 1.44 |
| EV / EBITDA | 8.30 |
| EV / EBIT | 11.10 |
| EV / FCF | 6.11 |
Financial Position
The company has a current ratio of 2.38, with a Debt / Equity ratio of 0.12.
| Current Ratio | 2.38 |
| Quick Ratio | 2.14 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.37 |
| Debt / FCF | 0.30 |
| Interest Coverage | 5.70 |
Financial Efficiency
Return on equity (ROE) is 21.62% and return on invested capital (ROIC) is 47.45%.
| Return on Equity (ROE) | 21.62% |
| Return on Assets (ROA) | 9.48% |
| Return on Invested Capital (ROIC) | 47.45% |
| Return on Capital Employed (ROCE) | 22.18% |
| Weighted Average Cost of Capital (WACC) | 11.52% |
| Revenue Per Employee | $1.27M |
| Profits Per Employee | $136,223 |
| Employee Count | 179 |
| Asset Turnover | 1.17 |
| Inventory Turnover | 6.65 |
Taxes
In the past 12 months, PBYI has paid $4.70 million in taxes.
| Income Tax | 4.70M |
| Effective Tax Rate | 16.17% |
Stock Price Statistics
The stock price has increased by +145.02% in the last 52 weeks. The beta is 1.21, so PBYI's price volatility has been higher than the market average.
| Beta (5Y) | 1.21 |
| 52-Week Price Change | +145.02% |
| 50-Day Moving Average | 7.29 |
| 200-Day Moving Average | 6.20 |
| Relative Strength Index (RSI) | 65.71 |
| Average Volume (20 Days) | 293,425 |
Short Selling Information
The latest short interest is 3.70 million, so 7.27% of the outstanding shares have been sold short.
| Short Interest | 3.70M |
| Short Previous Month | 3.80M |
| Short % of Shares Out | 7.27% |
| Short % of Float | 9.49% |
| Short Ratio (days to cover) | 18.69 |
Income Statement
In the last 12 months, PBYI had revenue of $227.18 million and earned $24.38 million in profits. Earnings per share was $0.48.
| Revenue | 227.18M |
| Gross Profit | 169.15M |
| Operating Income | 29.49M |
| Pretax Income | 29.09M |
| Net Income | 24.38M |
| EBITDA | 39.41M |
| EBIT | 29.49M |
| Earnings Per Share (EPS) | $0.48 |
Full Income StatementBalance Sheet
The company has $101.55 million in cash and $15.95 million in debt, giving a net cash position of $85.59 million or $1.68 per share.
| Cash & Cash Equivalents | 101.55M |
| Total Debt | 15.95M |
| Net Cash | 85.59M |
| Net Cash Per Share | $1.68 |
| Equity (Book Value) | 128.42M |
| Book Value Per Share | 2.52 |
| Working Capital | 82.52M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $53.61 million and capital expenditures -$10,000, giving a free cash flow of $53.60 million.
| Operating Cash Flow | 53.61M |
| Capital Expenditures | -10,000 |
| Depreciation & Amortization | 9.93M |
| Net Borrowing | -44.44M |
| Free Cash Flow | 53.60M |
| FCF Per Share | $1.05 |
Full Cash Flow StatementMargins
Gross margin is 74.46%, with operating and profit margins of 12.98% and 10.73%.
| Gross Margin | 74.46% |
| Operating Margin | 12.98% |
| Pretax Margin | 12.80% |
| Profit Margin | 10.73% |
| EBITDA Margin | 17.35% |
| EBIT Margin | 12.98% |
| FCF Margin | 23.59% |